Search research articles
Contact Us
Filters
Showing results (121-130 of 265) with videos related to
Page
of 27
Sort By:
International Journal of Cardiology
|
August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry
Fabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
Atherosclerosis
|
December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Patrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
Stroke
|
February 12, 2013
Efficacy and safety of vorapaxar in patients with prior ischemic stroke
David A Morrow, Mark J Alberts, Jay P Mohr, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 23, 2010
Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE
Hiroshi Inoue, Takashi Nozawa, Tadakazu Hirai, et al.
Frontiers in Veterinary Science
|
December 21, 2020
The Suppression of Th1 Response by Inducing TGF-β1 From Regulatory T Cells in Bovine Mycoplasmosis
Yamato Sajiki, Satoru Konnai, Shinya Goto, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
February 28, 2012
One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry
Norihiro Suzuki, Motoki Sato, Kiyohiro Houkin, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
April 8, 2014
Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age
Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
August 20, 2013
Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation in relation to the CHADS2 score: a subgroup analysis of the J-ROCKET AF trial
Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
November 6, 2013
Net clinical benefit of rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation: a subgroup analysis of J-ROCKET AF
Shinichiro Uchiyama, Masatsugu Hori, Masayasu Matsumoto, et al.
International Journal of Cardiology
|
May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality
Ronan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
Page
of 27
Search research articles
Search
Showing results (121-130 of 265) with videos related to
Sort By:
Page
of 27
International Journal of Cardiology
|
August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry
Fabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
Atherosclerosis
|
December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Patrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
Stroke
|
February 12, 2013
Efficacy and safety of vorapaxar in patients with prior ischemic stroke
David A Morrow, Mark J Alberts, Jay P Mohr, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 23, 2010
Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE
Hiroshi Inoue, Takashi Nozawa, Tadakazu Hirai, et al.
Frontiers in Veterinary Science
|
December 21, 2020
The Suppression of Th1 Response by Inducing TGF-β1 From Regulatory T Cells in Bovine Mycoplasmosis
Yamato Sajiki, Satoru Konnai, Shinya Goto, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
February 28, 2012
One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry
Norihiro Suzuki, Motoki Sato, Kiyohiro Houkin, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
April 8, 2014
Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age
Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
August 20, 2013
Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation in relation to the CHADS2 score: a subgroup analysis of the J-ROCKET AF trial
Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
November 6, 2013
Net clinical benefit of rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation: a subgroup analysis of J-ROCKET AF
Shinichiro Uchiyama, Masatsugu Hori, Masayasu Matsumoto, et al.
International Journal of Cardiology
|
May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality
Ronan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
Page
of 27